3 курс / Общая хирургия и оперативная хирургия / Мельцова_А_Ж_Использование_аллогенных_фибробластов_в_комплексном

141

207.Herrick S., Ireland G., Simon D, McCollum C., Ferguson M. Venous ulcer fibroblasts compared with normal fibroblasts show differences in collagen but not fibronectin production under both normal and hypoxic conditions.// J. Invest. Dermatol. – 1996. – Vol. 106, №1. – Р.187-193

208.Hjerppe A., Hjerppe M., Autio V., Raudasoja R., Vaalasti A. Treatment of Chronic Leg Ulcers with a Human Fibroblast-Derived Dermal Substitute: A Case Series of 114 Patients //Wounds. – 2004. – Vol. 16,№3. – P.97-104.

209.Horch R.; Stark G. Comparison of the effect of a collagen dressing and a polyurethane dressing on the healing of split thickness skin graft (STSG) donor sites. //Scand. J. Plast. Reconstr. Surg. Hand. Surg.-1998.-V.32, №4.–Р. 407-413.

210.Hulkko A., Holopainen Y.V., Orava S. et al. Comprparison of dextranomer and streptokinase-streptodornase in the treatment of venous leg ulcers and other infected wounds// Ann. Chir. Gynaec.-1981.-Vol. 70, № 2. – P.65-70.

211.Hynes R., Yamada K. Fibronectins: A multifunctional modular glycoproteins // J. Cell Biol. - 1982. - Vol.95, № 2.- P. 369-377.

212.Igel H.J., Freeman A.E., Boeckman C.K., Kleinfeld K.L. A new metod for cjvering large surface area wounds with autografts.// Arch. Surg.- 1974.- V.108, №5.

– P. 724-729.

213.Jantet G. Доклад председателя Международного Флебологического союза: Эпидемиология заболеваний вен. Обзор существующего положения // Флеболимфология. - 1997. – Спец. выпуск. - С.7-8.

214.Johnson S. Compression hosiery in the prevention and treatment of venous leg ulcers // J. Tissue Viability. – 2002. – Vol. 12, № 2. – P. 67-73.

215.Kane C., Hebda P., Mansbridge J. Direct evidence for spatial and temporal regilation of transforming growth factor 1 expression during cutaneous wound healing // J.Cell Physiol. - 1991. - Vol.148, № 2. - P. 157-173.

216.Karasek M. In vitro culture of human skin epithelial cell// J. Invest. Dermatol.- 1966. – №47. – P.533-540

217.Karasek M., Charlton M. Growth of postembrionic skin epithelial cells on collagen gels // J. Invest. Dermatol.- 1971. - Vol.56, № 2. - P. 205-210.

142

218.Kistner R.L. Surgical repair of the incompetent femoral vein valve // Arch. Surg.

– 1975. – Vol. 110, №11.- P.31-43.

219.Lait M.E.; Smith L.N Wound management: a literature review. //J. Clin Nurs.- 1998.-V.7,№1 – Р. 1-7 .

220.Lansdown A.B. Zinc in the healing wound // Lancet. - 1996. - Vol. 347, №.5 - P. 706-707.

221.Lazarus G., Cooper D., Knighton D., Margolis D., Pecoraro R., Rodeheaver G, Robson MC. Definitions and guidelines for assessment of wounds and evaluation of healing// Arch. Dermatol. – 1994. – Vol. 130, №4. – Р. 489-493.

222.Lees T.A., Lambert D. Prevalence of lower limb ulceration in an urban health district // Br. J. Surg. - 1992. – Vol. 79, №10. - P. 1032-1034.

223.Leigh I., Navsaria H., Purkis P., McKay I. Clinical practice and biological effects of keratinocyte grafting // Ann. Acad. Med. Singapore. – 1991.- Vol.20, №4. – Р. 549-555.

224.Lin S.D., Tsai C.C., Lin T.M., Lee S.S., Chang K.P., Lai C.S. Endoscopeassisted correction of primary varicose veins // Ann. Plast. Surg. – 2000. - Vol.44, №3. – P. 241-249.

225.Lin Y-C., Grinnel F. Decreased levfel of PDGF-stimulated receptor autophosphorylation by fibroblasts in mechanically relaxed collgen matrices// J.Cell Biol. -1993. - Vol.122, № 6. - P. 663-672.

226.Linton R. The communicating veins of the lower leg and the operative technic for their ligation // Ann. Surg. - 1938. - Vol. 107, № 4.- P. 582-593.

227.Mackie E., Halfer W., Livenari D. Induction of tenascin in healing wounds // J. Cell Biol. - 1988. - Vol.107, № 2. - P. 2757-2767.

228.Maeso J., Juan J., Escribano J., Allegue N.M. et al. Comparison of clinical outcome of stripping and CHIVA for treatment of varicose veins in the lower extremities // Ann. Vasc. Surg. – 2001. - Vol.15, №6. – P. 661-665.

229.Masuda E.M., Kistner R.L. Long term results of venous valve reconstruction: A four to twenty-one-year follow-up // J. Vasc. Surg.-1994. - Vol.19, №3. - P. 391-403.

143

230.Medawar P. The cultivation of adult mammalian skin epithelium in vitro//Quart. J.Microsc.Sci. - 1948. - Vol.89, № 2. - P. 187-196.

231.Mendez M., Raffetto J., Phillips T. et al: The proliferative capacity of neonatal skin fibroblasts is reduced after exposure to venous ulcer fluid: A potential mechanism for senescence in venous ulcers.// J. Vasc. Surg. – 1999. – Vol. 30, N 4.

– Р. 734-743.

232.Mendez M., Stanley A., Phillips T, Murphy M, Menzoian JO, Park HY. Fibroblasts cultured from distal lower extremities in patients with venous reflux display cellular characteristics of senescence.// J. Vasc. Surg. – 1998. – Vol. 28, №6.

– Р.1040-50.

233.Mizutani H., Black R., Kupper T. et al. Human keatinocytes produce but do not process prointerleukin-1. Different strategies of IL-1 production and processing in monocytes and keratinocytes // J.Clin.Invest. - 1991. - Vol.87, № 10.- P. 1066-1071.

234.Mooney E.K, Lippitt C., Reynolds R. Alternate Applications of Living Skin Equivalent // Wounds. – 2002.– Vol. 14, № 3. – P. 257 - 265

235.Nicolaides A.N. Investigation of chronic venous insufficiency // Circulation. – 2000. - Vol.102, №20. - P. 126-163.

236.O’Donnell T.F. Poplitea vein valve transplantation for deep venous valvular reflux: rationale, metod, and long term clinical, hemodynamic, and anatomic results// Venous disorders / Eds. Bergan J.J., Yao J.S. – London: Sounders, 1991. – P.273-

237.O'Connor N., Mulliken J., Banks-Schlegel S. et al. Grafting of burns with cultured epithelium prepared from autologous epidermal cells// Lancet. - 1981. - Vol. 1, № 8211. -P.75-78.

238.Odessey R. Addendum: multicenter experience with cultured epidermal autograft for treatment of burns //J.Burn Care Rehab. - 1992. - Vol.13, № 1. - P. 174-

239.Palfreyman S., Lochiel R., Michaeles J. F systematic review of compression therapy for venous leg ulcers // Vasc. Med. – 1998. – Vol. 3, № 4. – P.301-313.

144

240.Palma E., Esperon R. Vein transplantation and grafts in the surgical treatment of the postphlebitic syndrome// J. cardiovasc. surg.-1960.- № I. – P.94-96.

241.Patton M., McCutchan K., Goldman W. Treatment of the massive adult burn wounds with cultured epithelia autografts // 8-th International Congress on Burn Injuries. - New Delhi, 1990. - Р. 59.

242.Pham H., Rosenblum B., Lyons T. et al. Evaluation of human skin equivalent for the treatment of diabetic foot ulcers in a prospective, randomised, clinical trial. // Wounds. – 1999. – Vol.11, №4. – Р. 79-86.

243.Phillips T., Gilchrest B. Clinical applications of cultured epithelium. // Epithelial Cell Biol. – 1992. – Vol.1, №1. – Р. 39-46.

244.Phillips T., Manzoor J., Rojas A. et al. The longevity of a bilayered skin substitute after application to venous ulcers.// Arch. Dermatol. - 2002. –Vol. 138, №8. – Р.1079-1081.

245.Phillips Т., Stanton В., Provan A. et al. A study of the impact of the leg ulcers on quality of life: financial, social and psychologic implications // J. Am. Acad. Dermatol. - 1994. –Vol.31, №1. -P. 83-86.

246.Pierce G., Yanagihara D., Klopchin K. et al. Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor // J.Exp.Med. -1994. - Vol.179, № 8.- P. 831-840.

247.Porter J.M., Moneta G.L. Reporting standards in venous disease: an up-date International Consensus Committee on Chronic Venous Disease // J. Vasc. Surg. - 1995. - Vol.21, № 4. - P. 635-645.

248.Raffetto J., Mendez V., Marien B., Byers H., Phillips T., Park H., Menzoian J. Changes in cellular motility and cytoskeletal actin in fibroblasts from patients with chronic venous insufficiency and in neonatal fibroblasts in the presence of chronic wound fluid.// J. Vasc. Surg. – 2001. - Vol 33№6. – Р.1233-1241.

249.Raffetto J., Mendez V., Phillips T. et al: The effect of passage number on fibroblast cellular senescence in patients with chronic venous insufficiency with and without ulcer.// Am. J. Surg. – 1999. – Vol. 178, № 2. – Р.107-112.

145

250.Ramelet A.A., Coleridge S., Gloviczki P. Factors affecting venous leg ulcer healing. Abstracts of the 21st World Congress of the International Union of Angiology // Int. Angiol. – 2004. – Vol. 23, Suppl.1. – Р.158.

251.Ramsden L., Rider C. Selective and differential binding of interleukin IL-1, IL-2 and IL-6 to dlycosaminoglycans // Eur. J. Immunol. - 1992. - Vol.22, № 11. - P. 3027-3031.

252.Rheinwald J., Green H. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizating colonies from single cells // Ibid. - 1975. - Vol.6, № 4. - P. 331-344.

253.Robson M., Hill D., Smith P., Wang X., Meyer-Siegler K., Ko F. et al. Sequential cytokine therapy for pressure ulcers: clinical and mechanistic response// Ann Surg. – 2000. - Vol 231, №4. – P.600-611.

254.Ruckley C.V. Socioeconomic impact of chronic venous insufficiency and leg ulcer // Angiology. - 1997. - №.48, №1. - P. 67-69.

255.Sage H., Vernon R., Funk S. et al. SPARC , a secreted protein associated with cell proliferation, inhibits cell spreading in vitro and exhibits Ca 5+2 0-dependent binding to the ECM// J.Cell Biol. - 1989.- Vol.109, № 1. - P. 341-356.

256.Schalkwjik J., Steijen P. I van Vlijmen-Willems et al. Tenascin expression in human dermis is related to epidermal proliferation // Amer. J. Pathol. - 1991. - Vol.139, № 5.- P. 1143-1149.

257.Seidman C., Raffetto J.D., Marien B.J., et al: bFGF induced alterations in cellular markers of senescence in growth rescued fibroblasts from chronic venous ulcer and venous reflux patients// Ann Vasc Surg. – 2003. – Vol. 17, № 3. – P.239-

258.Skornik W.A., Dressler D.P. Burn wound dressings.//J. Trauma. - 1971. – Vol.11, № 4. - P.317-330.

259.Slavin J. The role of cytokines in wound healing// J Pathol. – 1996. – Vol. 178,№1. –P. 5-10.

260.Smiell J., Wieman T., Steed D., Perry B., Sampson A., Schwab B. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in

146

patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies// Wound Repair Regen. – 1999. - Vol 7,№5. – P. 335-346.

261.Smith P.C. Venous ulcer// Br. J. Surg. – 1994. – Vol.81, № 10. – P.1404-1405

262.Smith P.C. Рекомендации по консервативному лечению хронической венозной нижних конечностей поздних стадий и местному лечению трофических язв // Флеболимфология.-2004.-.№22.-С.31.

263.Staiano-Coico L., Krueger J., Rubin J. et al. Human keratinocyte growth factor effects in a porcine model of epidermal wound healing // J. Exp. Med. - 1993. - Vol.178, №8.- P. 865-878.

264.Stanley A., Park H., Phillips T., Russakovsky V., Menzoian J. Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors// J. Vasc. Surg. – 1997. – Vol. 26, №6. –P. 994-999.

265.Steed D. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group //J. Vasc. Surg. – 1995. - Vol 21,№1. – Р. 71-78.

266.Strand L., Madsen H.C. Subfasciel endoskopisk sanering af perforantvener. Erfaringer med de forste 100 operationer. // Ugeskr. Laeger. – 2001. – Vol.163, № 6.

– P. 747-749

267.Strandness D.E., Thiele B.L. Selected typies in venous disorders: (Pathophysiology, diagnosis and treatment). - New York: Futura Pub., 1981. - 270 p.

268.Taheri S.A., Lazar L., Elias S.M. Surgical treatment of post phlebitic syndrome// Vasc. Surg. – 1982. – Vol. 16, №6. – P. 341-352.

269.Tessari L., Cavezzi A., Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins // Dermatol. Surg. – 2001. – Vol.27, №1. – P. 58-60.

270.Thomas S. Lawrence J. Thomas A. Evaluation of hydrocolloids and topical medication in minor burns.// J. Wound Care.-1995.-V.4, №5. - Р.218-220.

271.Thomas S. Wound management and dressing. - London: Pharmaceutical Press, 1990.- 407 p.

147

272.Tomic-Canic M., Brem H. Gene array technology and pathogenesis of chronic wounds // Am. J. Surg. – 2004. – Vol.188, Suppl. 1A. – Р. 67 - 72.

273.Trent J.F., Kirsner R.S. Tissue engineered skin: Apligraf, a bilayered living skin equivalent // Int. J. Clin. Pract. – 1998. – Vol. 52, № 6. - Р.408-413.

274.Tsuboi R., Sato C., Kurita Y. et al. Keratinocyte growth factor (FGF=7) stimulates migration and plasminogen activator activity of normal human

keratinocytes//J. Invest. Dermatol.-1993.- Vol.101, № 1.-P.49-53.

275.Van Rijswijk L., Beitz J. The traditions and terminology of wound dressings: food for thought // J. Wound Ostomy Continence Nurs. – 1998. - Vol 25, № 3. –Р. 116-122.

276.Vande Berg J., Rudolph R., Hollan C., Haywood-Reid P. Fibroblast senescence in pressure ulcers //Wound Repair Regen. – 1998. – Vol. 6,№1. – Р.38-49.

277.Vasquez R., Marien B., Gram C. et al. Proliferative capacity of venous ulcer wound fibroblasts in the presence of platelet-derived growth factor // Vasc. Endovasc. Surg. – 2004. – Vol. 38, № 4. – Р.355-360.

278.Veves A., Falanga V., Armstrong D., Sabolinski M. Graftskin, a human skin equivalent, is effective in the management of non-infected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial // Diabetes Care. – 2001. – Vol. 24,№2. – Р. 290-295.

279.Vowden K, Vowden P. Wound bed preparation. – http://www.worldwidewounds.com/2002/april/Vowden/Wound - Bed - Preparation. html. – 2002.

280.Wasserman D., Cuelfi M., Schlotterer M. et al. Topical use of Cerium Nitrate added to siver sulfadiazine. Clinical results in major burns and local effects on wounds // The 8-th International Congress on Burn Injuries. - New Delhi, 1990. - P.

281.West D., Hampson I., Arnold F., Kumar S. Angiogenesis induced by degradation products of hyaluronic acid // Science.– 1985.– Vol.228, № 4705. – Р. 1324-1326.

148

282.Whitby D., Growth factors and wound healing //The Sixth Congress of the European Burn Association. - Verona,1995. – P. 140.

283.Wikner N., Dixit V.M., Frazier W.A., Clark R.A. Human keratinocytes synthesize and secrete the extracellular matrix protein, thrombospondin.// J. Invest. Dermatol. - 1987. - Vol.88 , № 2. - P. 207-211.

284.Wikner N., Persichitte K., Baskin J. et al. Transforming growth factor-b stimulates the expression of fibronectin by human keratinocytes // J. Invest. Dermatol. - 1988.- Vol.91, № 3. - P. 207-212.

285.Williams C. Hydrocoll: A «new breed» of hydrocolloid wound dressing. //Br. J. Nursing. - 1998.-V.7, №21. –Р. 1337-1340

286.Williams C. Leg ulcer after care: the role of compression hosiery // Br. J. Nursing. – 2000. – Vol. 9, № 13. – P. 822-888.

287.Wilson N.M., Rutt D.L., Browse N.L. Repair and replacement of deep vein valves in the treatment of venous insufficiency // Brit. J. Surg. - 1991. - Vol.78, №4. - P. 388-394.

288.Wokalek H., Heinder R. Enzymatische Wundreinigang // Eztr. Medica Practica. - 1984.- Bd. 5, Suppl. 1.- S. 35-42.